Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DEM51671Aexternal-prioritypatent/DE1210817B/de
Application filed by E Merck AGfiledCriticalE Merck AG
Application grantedgrantedCritical
Publication of FR2476MpublicationCriticalpatent/FR2476M/fr
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
FR922848A1962-02-011963-01-28Nouveaux stéroides de la série de l'androstane.
ActiveFR2476M
(fr)
Fremgangsmåde til fremstilling af 2'-acetamido-2'-desoxyglucosider eller -galactosider af 17α,21-dihydroxy-11-oxygenerede -3,20-diketo-steroider af pregnanrækken.
Stéroides 17α-dihalocyclopropényle et 17α-dihalocyclopropyle substitué de la série de l'oestra-1,3,5(10)triene,4 androsténe et 19-nor-4-androsténe.